Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2014

Sep 16, 2014

6990_rns_2014-09-16_1c254e2d-4759-49a8-80ea-714893909502.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response 0.5

1. Name and Address of Reporting Person* Aberman Zami 0001344740
(Last) (First) (Middle)
46 HATAPUZ ST.
(Street)
TELMOND L3 40600
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol PLURISTEM THERAPEUTICS INC [PSTI]
---
3. Date of Earliest Transaction (Month/Day/Year) 09/16/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
--- ---
X Director
X Officer (give title below)
CEO & Chairman
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
--- ---
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)
Common Stock 09/16/2014
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
--- ---
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security

Explanation of Responses:

  1. The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.14, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.626 per U.S. dollar.

Remarks:

/s/ Zami Aberman ** Signature of Reporting Person

09/16/2014 Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.